Trisha Peel
Biographic Data
| ID | 9800096 |
|---|---|
| NAME | Trisha Peel |
| GIVEN NAMES | Trisha |
| FAMILY NAME | Peel |
| SIGNATURE | PEEL T |
| AFFILIATIONS | Alfred Health |
| ORCID | 0000-0003-2370-2438 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Evaluation of a One Health programme to address antimicrobial resistance in Pacific Island Countries
The emergence and spread of antimicrobial-resistant organisms is a major global health challenge. We report on the approach and outcomes of a programme which aimed to take a One Health approach, incorporating an understanding that the health of humans, animals and the environment are linked. Combating the Threat of Antimicrobial Resistance in Pacific Island Countries (COMBAT-AMR) was funded by the Australian Department of Foreign Trade and design…
Development of a cross-sectoral antimicrobial resistance capability assessment framework
Antimicrobial resistance (AMR) is an urgent and growing global health concern, and a clear understanding of existing capacities to address AMR, particularly in low-income and middle-income countries (LMICs), is needed to inform national priorities, investment targets and development activities. Across LMICs, there are limited data regarding existing mechanisms to address AMR, including national AMR policies, current infection prevention and antim…
Antimicrobial resistance in the Pacific Island countries and territories
Antimicrobial resistance (AMR) is a critical global health threat with a disproportionate impact on low-income and middle-income countries (LMICs) due to their higher burden of infections, reduced laboratory surveillance infrastructure and fewer regulations governing antimicrobial use among humans or animals. While there have been increasing descriptions of AMR within many LMICs in WHO’s Western Pacific and South East Asian regions, there remains…
No prominent works on this page.
Antimicrobial resistance in the Pacific Island countries and territories
Antimicrobial resistance (AMR) is a critical global health threat with a disproportionate impact on low-income and middle-income countries (LMICs) due to their higher burden of infections, reduced laboratory surveillance infrastructure and fewer regulations governing antimicrobial use among humans or animals. While there have been increasing descriptions of AMR within many LMICs in WHO’s Western Pacific and South East Asian regions, there remains…
Development of a cross-sectoral antimicrobial resistance capability assessment framework
Antimicrobial resistance (AMR) is an urgent and growing global health concern, and a clear understanding of existing capacities to address AMR, particularly in low-income and middle-income countries (LMICs), is needed to inform national priorities, investment targets and development activities. Across LMICs, there are limited data regarding existing mechanisms to address AMR, including national AMR policies, current infection prevention and antim…
Evaluation of a One Health programme to address antimicrobial resistance in Pacific Island Countries
The emergence and spread of antimicrobial-resistant organisms is a major global health challenge. We report on the approach and outcomes of a programme which aimed to take a One Health approach, incorporating an understanding that the health of humans, animals and the environment are linked. Combating the Threat of Antimicrobial Resistance in Pacific Island Countries (COMBAT-AMR) was funded by the Australian Department of Foreign Trade and design…
Antibiotic Use and Resistance (3 works) · Business (2 works) · Capacity building (2 works) · Economic growth (2 works) · Economics (2 works) · Global health (2 works) · Global Maternal and Child Health (2 works) · Medicine (2 works) · Political science (2 works) · Antibiotic Resistance in Bacteria (1 work)